Prediction of Ki-67 expression in hepatocellular carcinoma with machine learning models based on intratumoral and peritumoral radiomic features [0.03%]
基于肿瘤内和肿瘤周影像组学特征的机器学习模型预测肝癌Ki-67表达量
Zi-Wei Zhu,Jun Wu,Yang Guo et al.
Zi-Wei Zhu et al.
Background: Hepatocellular carcinoma (HCC) is one of the most common malignant tumours of the digestive system worldwide. The expression of Ki-67 is crucial for the diagnosis, treatment, and prognostic evaluation of HCC. ...
Research status and trends of deep learning in colorectal cancer (2011-2023): Bibliometric analysis and visualization [0.03%]
2011-2023年人工智能在结直肠癌研究中的现状与趋势：文献计量分析及可视化
Lu-Ying Qi,Bai-Wang Li,Jie-Qiong Chen et al.
Lu-Ying Qi et al.
Background: Colorectal cancer (CRC) is the third-most prevalent cancer and the cancer with the second-highest mortality rate worldwide, representing a high public health burden. Deep learning (DL) offers advantages in the...
Research status and progress of deep learning in automatic esophageal cancer detection [0.03%]
基于深度学习的食管癌自动检测研究进展与现状分析
Jing Chen,Xin Fan,Qiao-Liang Chen et al.
Jing Chen et al.
Esophageal cancer (EC), a common malignant tumor of the digestive tract, requires early diagnosis and timely treatment to improve patient prognosis. Automated detection of EC using medical imaging has the potential to increase screening eff...
Esophageal involvement of mantle cell lymphoma presenting with multiple lymphomatous polyposis: A single-center study [0.03%]
套细胞淋巴瘤食管受累多发淋巴样息肉型：单中心研究
Makoto Saito,Yoshitaka Oda,Hirokazu Sugino et al.
Makoto Saito et al.
Background: In addition to nodal lesions, over 30% of mantle cell lymphomas (MCLs) also have gastrointestinal involvement, characteristically presenting as multiple lymphomatous polyposis (MLP), which rarely involve the e...
Nomogram-based strategy to predict relapse-free survival in patients with gastrointestinal stromal tumor using inflammatory indicators [0.03%]
基于炎症指标的胃肠间质瘤患者无复发生存预测列线图策略
Shashank Kumar
Shashank Kumar
Zhao et al's investigation on the assessment of inflammatory markers prognostic value for relapse-free survival in patients with gastrointestinal stromal tumor (GIST) using a nomogram-based approach is a scientific approach. This study expl...
Significance of serum APE1-AAbs, PTX-3, and miR-486-3p in patients with colorectal cancer undergoing radical surgery [0.03%]
APE1-AAbs、PTX-3和miR-486-3p在结直肠癌根治术后患者血清中的意义
Hao Wang,Wei Wang
Hao Wang
Background: Colorectal cancer (CRC) is a common malignant tumor of the digestive tract worldwide, characterized by high incidence and mortality rates. Aim...
Novel tumor marker index combining carcinoembryonic antigen and carbohydrate antigen 19-9: New prognostic factor for metastatic colorectal cancer [0.03%]
一种新的肿瘤标志物指数联合癌胚抗原和糖类抗原19-9：新发现的转移性结直肠癌预后因素
Yusuf Ilhan,Onur Yazdan Balcik,Halil Goksel Guzel et al.
Yusuf Ilhan et al.
Background: Metastatic colorectal cancer (mCRC) is a global health challenge with a poor prognosis. Prognostic markers are critical for survival prediction. ...
SPDL1 inhibition enhances colorectal cancer progression via epidermal growth factor receptor/extracellular signal-regulated kinase pathways [0.03%]
SPDL1抑制通过表皮生长因子受体/细胞外信号调节酶激酶途径促进结直肠癌进展
Peng Peng,Juan Sun,Meng-Shi Li et al.
Peng Peng et al.
Background: In patients with colorectal cancer (CRC), tumour metastasis is the leading cause of death. The search for key genes involved in metastasis of CRC is imperative for improved prognoses and treatments. SPDL1 has ...
Development and validation of machine learning nomograms for predicting survival in stage IV pancreatic cancer: A retrospective study [0.03%]
用于预测IV期胰腺癌患者生存结果的机器学习 Nomogram 的开发和验证：一项回顾性研究
Kun Huang,Zhu Chen,Xin-Zhu Yuan et al.
Kun Huang et al.
Background: Stage IV pancreatic cancer (PC) has a poor prognosis and lacks individualized prognostic tools. Current survival prediction models are limited, and there is a need for more accurate, personalized methods. The ...
Validation and analysis of key factors of Banxia Xiexin decoction against gastric cancer [0.03%]
半夏泻心汤治疗胃癌有效性和关键因素分析
Guo-Xiu Zu,Ji-Qin Tang,Hai-Liang Huang et al.
Guo-Xiu Zu et al.
Background: In China Banxia Xiexin decoction (BXD) has been used in treating gastric cancer (GC) for thousands of years. BXD has been shown to reverse GC histopathology, but its chemical composition and action mechanism a...